Ciliary神经营养因子在 ангиотензин II 诱导的高血压中的作用
Sebastian A Potthoff1, Ivo Quack1, Yuri Mori2
1Department of Nephrology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany (S.A.P., I.Q., D. Arifaj, M.K., D. Argov, L.C.R., J.S.).
Hypertension (Dallas, Tex. : 1979)
|January 24, 2025
概括
状神经变因子 (CNTF) 通过调节血管新生素II诱导的反应,在调节血压方面发挥着关键作用. 这种细胞因子通过一个依赖于JAK2/STAT3的途径影响高血压,突出其在心血管调节中的重要性.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 分子医学是分子医学.
背景情况:
- 状神经变因子 (CNTF) 是IL-6细胞因子家族的成员,主要以其神经保护作用而闻名.
- CNTF对血管功能的影响及其在高血压中的作用在很大程度上仍未被探索.
- 这项研究调查了CNTF在血管素II (AngII) 诱导的高血压中的作用.
研究的目的:
- 阐明CNTF在AngII诱导高血压的发展和调节中的作用.
- 检查CNTF对血管对AngII的反应的影响.
- 调查 CNTF 对血压影响的潜在分子机制,特别是 JAK2 / STAT3 途径.
主要方法:
- 利用CNTF敲击和野生型小鼠研究AngII诱导的高血压.
- 使用尾巴手和射电测量方法测量血压.
- 评估血管功能,压应答和JAK2/STAT3通路激活 in vivo,ex vivo (隔离过的脏) 和 in vitro (血管光滑肌细胞).
主要成果:
- 与野生类型小鼠相比,CNTF-Knockout小鼠在应对AngII时表现出减弱的血压增加和减少高血压器官损伤.
- 在CNTF淘汰赛小鼠中,对AngII的压器反应显著下降,这种效果在急性CNTF给药时被部分恢复.
- 发现CNTF增强了血管光滑肌细胞中AngII诱导的JAK2 / STAT3通路激活,这是它对血压影响至关重要的机制.
结论:
- 通过调节AngII诱导的压力反应,CNTF显著影响血压调节.
- 观察到的CNTF的效果是通过一个JAK2/STAT3依赖的机制调解的.
- 在高血压的背景下,CNTF成为一种关键的调节性细胞因子.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
463
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
463
Antihypertensive Drugs: Angiotensin II Receptor Blockers
576
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
576
Antihypertensive Drugs: Direct Renin Inhibitors
480
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
480
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
376
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
376
Antihypertensive Drugs: Action of β1 Blockers
306
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
306
Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K


